These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38396200)

  • 21. Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population.
    Lee SW; Lee TY; Yang SS; Tung CF; Yeh HZ; Chang CS
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):45-48. PubMed ID: 29428103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impacts of types and degree of obesity on non-alcoholic fatty liver disease and related dyslipidemia in Chinese school-age children?
    Meng L; Luo N; Mi J
    Biomed Environ Sci; 2011 Feb; 24(1):22-30. PubMed ID: 21440836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of circulating adipsin with nonalcoholic fatty liver disease in obese adults: a cross-sectional study.
    Zhang J; Li K; Pan L; Teng F; Zhang P; Lin B; Yuan Y; Wei X; Li W; Zhang H
    BMC Gastroenterol; 2021 Mar; 21(1):131. PubMed ID: 33743586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
    Suh JB; Kim SM; Cho GJ; Choi KM
    Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating periostin in relation to insulin resistance and nonalcoholic fatty liver disease among overweight and obese subjects.
    Yang Z; Zhang H; Niu Y; Zhang W; Zhu L; Li X; Lu S; Fan J; Li X; Ning G; Qin L; Su Q
    Sci Rep; 2016 Nov; 6():37886. PubMed ID: 27885258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
    Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
    World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the ability of insulin resistance and lipid-related indices to predict the presence of NAFLD in obese adolescents.
    Yetim A; Şahin M; Kandemir İ; Bulakçı B; Aksakal MT; Karapınar E; Sever H; Baş F
    Lipids Health Dis; 2024 Jul; 23(1):208. PubMed ID: 38956572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease.
    Kuang M; Sheng G; Hu C; Lu S; Peng N; Zou Y
    Lipids Health Dis; 2022 Oct; 21(1):104. PubMed ID: 36266655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
    Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing, China].
    Zhou X; Hou DQ; Duan JL; Sun Y; Cheng H; Zhao XY; Liu JT; Yang P; Shan XY; Mi J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 May; 34(5):446-50. PubMed ID: 24016432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients with nonalcoholic fatty liver disease display increased serum resistin levels and decreased adiponectin levels.
    Jiang LL; Li L; Hong XF; Li YM; Zhang BL
    Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):662-6. PubMed ID: 19282764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased Prolactin is an Adaptive Response to Protect Against Metabolic Disorders in Obesity.
    Liu J; Wang Q; Zhang L; Fu J; An Y; Meng H; Wang G
    Endocr Pract; 2021 Jul; 27(7):728-735. PubMed ID: 33637446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The characteristics of non-alcoholic fatty liver disease and its associated factors in patients with rheumatoid arthritis].
    Wu T; Zou YW; Ma JD; Chen CT; Zhang XP; Lin JZ; Xu YH; Yang KM; Zhang Q; Zou YY; Mo YQ; Dai L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 May; 56(5):574-582. PubMed ID: 35644970
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
    Chakrabarty M; Jha AN; Sharma DJ
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A significant association of non-obese non-alcoholic fatty liver disease with sarcopenic obesity.
    Kashiwagi K; Takayama M; Fukuhara K; Shimizu-Hirota R; Chu PS; Nakamoto N; Inoue N; Iwao Y; Kanai T
    Clin Nutr ESPEN; 2020 Aug; 38():86-93. PubMed ID: 32690183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children.
    Prokopowicz Z; Malecka-Tendera E; Matusik P
    Can J Gastroenterol Hepatol; 2018; 2018():9465784. PubMed ID: 29854716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of serum irisin levels to obesity and non-alcoholic fatty liver disease.
    Ulualan G; Kiraz ZK; Kırel B
    Turk J Pediatr; 2022; 64(2):246-254. PubMed ID: 35611413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum C1q/TNF-related protein 9 is not related to nonalcoholic fatty liver disease.
    Zhang C; Zhou N; Qiu P; Fu Y; Liu Z; Li H; Yang X; Zhang L
    Cytokine; 2018 Oct; 110():52-57. PubMed ID: 29704818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Association between Vitamin D Insufficiency and Nonalcoholic Fatty Liver Disease: A Population-Based Study.
    Ha Y; Hwang SG; Rim KS
    Nutrients; 2017 Jul; 9(8):. PubMed ID: 28749418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease.
    Shao C; Ye J; Li F; Feng S; Wang W; Zhong B
    Dig Liver Dis; 2019 Oct; 51(10):1392-1399. PubMed ID: 30928418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.